← Back to all trials
Active Not Recruiting
NCT05683353
Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors
Conditions: SARS-CoV-2 Infection, Hematologic Malignancy
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: Yes
Enrollment: 60
Sponsor: Peking University First Hospital
Location: Peking University First Hospital Beijing Beijing Municipality
Summary
The goal of this observational study is to compare the immune function and infection mechanism of patients with hematologic tumors and those people without underlying diseases after infection with SARS-CoV-2. Clinical characteristics, treatment options and responses will be collected. Peripheral blood will be collected from patients with hematologic tumors infected with SARS-CoV-2 and those people without underlying diseases infected with SARS-CoV-2.
Eligibility Criteria
Inclusion Criteria:
\- Clinical diagnosis of hematologic tumors Clinical diagnosis of SARS-CoV-2 infection
Exclusion Criteria:
\- Severe diseases associated with other systems
Source: ClinicalTrials.gov (NCT05683353). StuddyBuddy aggregates publicly available trial information.
